244 related articles for article (PubMed ID: 28451919)
1. A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome.
Lau AA; King BM; Thorsen CL; Hassiotis S; Beard H; Trim PJ; Whyte LS; Tamang SJ; Duplock SK; Snel MF; Hopwood JJ; Hemsley KM
J Inherit Metab Dis; 2017 Sep; 40(5):715-724. PubMed ID: 28451919
[TBL] [Abstract][Full Text] [Related]
2. An Engineered
Douek AM; Amiri Khabooshan M; Henry J; Stamatis SA; Kreuder F; Ramm G; Änkö ML; Wlodkowic D; Kaslin J
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073041
[TBL] [Abstract][Full Text] [Related]
3. Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIA.
Webber DL; Choo A; Hewson LJ; Trim PJ; Snel MF; Hopwood JJ; Richards RI; Hemsley KM; O'Keefe LV
Exp Neurol; 2018 May; 303():38-47. PubMed ID: 29408731
[TBL] [Abstract][Full Text] [Related]
4. Reduction in Brain Heparan Sulfate with Systemic Administration of an IgG Trojan Horse-Sulfamidase Fusion Protein in the Mucopolysaccharidosis Type IIIA Mouse.
Boado RJ; Lu JZ; Hui EK; Pardridge WM
Mol Pharm; 2018 Feb; 15(2):602-608. PubMed ID: 29251941
[TBL] [Abstract][Full Text] [Related]
5. Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes.
Fraldi A; Hemsley K; Crawley A; Lombardi A; Lau A; Sutherland L; Auricchio A; Ballabio A; Hopwood JJ
Hum Mol Genet; 2007 Nov; 16(22):2693-702. PubMed ID: 17725987
[TBL] [Abstract][Full Text] [Related]
6. A Preclinical Study Evaluating AAVrh10-Based Gene Therapy for Sanfilippo Syndrome.
Winner LK; Beard H; Hassiotis S; Lau AA; Luck AJ; Hopwood JJ; Hemsley KM
Hum Gene Ther; 2016 May; 27(5):363-75. PubMed ID: 26975339
[TBL] [Abstract][Full Text] [Related]
7. Systemic scAAV9.U1a.hSGSH Delivery Corrects Brain Biochemistry in Mucopolysaccharidosis Type IIIA at Early and Later Stages of Disease.
Saville JT; Derrick-Roberts ALK; McIntyre C; Fuller M
Hum Gene Ther; 2021 Apr; 32(7-8):420-430. PubMed ID: 33339477
[TBL] [Abstract][Full Text] [Related]
8. Intracerebroventricular dosing of N-sulfoglucosamine sulfohydrolase in mucopolysaccharidosis IIIA mice reduces markers of brain lysosomal dysfunction.
Magat J; Jones S; Baridon B; Agrawal V; Wong H; Giaramita A; Mangini L; Handyside B; Vitelli C; Parker M; Yeung N; Zhou Y; Pungor E; Slabodkin I; Gorostiza O; Aguilera A; Lo MJ; Alcozie S; Christianson TM; Tiger PMN; Vincelette J; Fong S; Gil G; Hague C; Lawrence R; Wendt DJ; Lebowitz JH; Bunting S; Bullens S; Crawford BE; Roy SM; Woloszynek JC
J Biol Chem; 2022 Dec; 298(12):102625. PubMed ID: 36306823
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA.
Crawley AC; Gliddon BL; Auclair D; Brodie SL; Hirte C; King BM; Fuller M; Hemsley KM; Hopwood JJ
Brain Res; 2006 Aug; 1104(1):1-17. PubMed ID: 16828069
[TBL] [Abstract][Full Text] [Related]
10. The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome).
Meyer A; Kossow K; Gal A; Steglich C; Mühlhausen C; Ullrich K; Braulke T; Muschol N
Hum Mutat; 2008 May; 29(5):770. PubMed ID: 18407553
[TBL] [Abstract][Full Text] [Related]
11. Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy.
Chen Y; Zheng S; Tecedor L; Davidson BL
Mol Ther; 2018 Apr; 26(4):1118-1126. PubMed ID: 29503202
[TBL] [Abstract][Full Text] [Related]
12. An immune deficient mouse model for mucopolysaccharidosis IIIA (Sanfilippo syndrome).
Pollock K; Noritake S; Imai DM; Pastenkos G; Olson M; Cary W; Yang S; Fierro FA; White J; Graham J; Dahlenburg H; Johe K; Nolta JA
Sci Rep; 2023 Oct; 13(1):18439. PubMed ID: 37891179
[TBL] [Abstract][Full Text] [Related]
13. Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice.
Mader KM; Beard H; King BM; Hopwood JJ
Genes Brain Behav; 2008 Oct; 7(7):740-53. PubMed ID: 18518922
[TBL] [Abstract][Full Text] [Related]
14. Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice.
Mohammed EE; Snella EM; Rutz-Mendicino MM; Echevarria FD; Awedikian R; Whitley EM; Ellinwood NM
Mol Genet Metab; 2012 Sep; 107(1-2):129-35. PubMed ID: 22867887
[TBL] [Abstract][Full Text] [Related]
15. Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier.
Maccari F; Sorrentino NC; Mantovani V; Galeotti F; Fraldi A; Volpi N
Metab Brain Dis; 2017 Feb; 32(1):203-210. PubMed ID: 27585464
[TBL] [Abstract][Full Text] [Related]
16. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)].
Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT
Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774
[TBL] [Abstract][Full Text] [Related]
17. Myeloid/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease.
Sergijenko A; Langford-Smith A; Liao AY; Pickford CE; McDermott J; Nowinski G; Langford-Smith KJ; Merry CL; Jones SA; Wraith JE; Wynn RF; Wilkinson FL; Bigger BW
Mol Ther; 2013 Oct; 21(10):1938-49. PubMed ID: 23748415
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor antibody-sulfamidase fusion protein penetrates the primate blood-brain barrier and reduces glycosoaminoglycans in Sanfilippo type A cells.
Boado RJ; Lu JZ; Hui EK; Pardridge WM
Mol Pharm; 2014 Aug; 11(8):2928-34. PubMed ID: 24949884
[TBL] [Abstract][Full Text] [Related]
19. An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA.
Gray AL; O'Leary C; Liao A; Agúndez L; Youshani AS; Gleitz HF; Parker H; Taylor JT; Danos O; Hocquemiller M; Palomar N; Linden RM; Henckaerts E; Holley RJ; Bigger BW
Hum Gene Ther; 2019 Sep; 30(9):1052-1066. PubMed ID: 31020862
[TBL] [Abstract][Full Text] [Related]
20. Axonal dystrophy in the brain of mice with Sanfilippo syndrome.
Beard H; Hassiotis S; Gai WP; Parkinson-Lawrence E; Hopwood JJ; Hemsley KM
Exp Neurol; 2017 Sep; 295():243-255. PubMed ID: 28601604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
